Toward Next Generation Lateral Flow Assays: Integration of Nanomaterials
Year: 2022
Type: review
Abstract: Lateral flow assays (LFAs) are currently the most used point-of-care sensors for both diagnostic (e.g., pregnancy test, COVID-19 monitoring) and environmental (e.g., pesticides and bacterial monitoring) applications. Although the core of LFA technology was developed several decades ago, in recent years the integration of novel nanomaterials as signal transducers or receptor immobilization platforms has brought improved analytical capabilities. In this Review, we present how nanomaterial-based LFAs can address the inherent challenges of point-of-care (PoC) diagnostics such as sensitivity enhancement, lowering of detection limits, multiplexing, and quantification of analytes in complex samples. Specifically, we highlight the strategies that can synergistically solve the limitations of current LFAs and that have proven commercial feasibility. Finally, we discuss the barriers toward commercialization and the next generation of LFAs.
Source: Chemical Reviews
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $5,000
Funders: Centres de Recerca de Catalunya, Institut Català de Nanociència i Nanotecnologia, Graphene Flagship, European Commission, Generalitat de Catalunya, Ministerio de Ciencia e Innovación, Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España, Horizon 2020 Framework Programme, Consejo Superior de Investigaciones Científicas, Instituto de Salud Carlos III, European Regional Development Fund, Agencia Estatal de Investigación, H2020 Marie Skłodowska-Curie Actions, NextGenerationEU
Awards: G1175115578, G121809054, G1288213089, G1341303, G1575699983, G1799927510, G1855990336, G193230900, G210041235, G2110243209, G2115222242, G2262748287, G2309174360, G2462415295, G2601397997, G2660406951, G2713276326, G279363373, G2913093573, G300979063, G318412399, G3243756204, G34346518, G3480869486, G3518538256, Nano-Monitoreo de la eficacia de un tratamiento inmunoterapéutico contra el cáncer: La plataforma de bioensayo electroforético lateral, G3681454997, G4042783231, G425668148, G430777504, G43203158, G434337789, G4662551690, G4871304133, G4993905653, G5080475149, Graphene Flagship Core Project 3, G5195188938, G521056402, G5421974903, G571045394, PREvention of MOther-to-child Transmission of HIV and Syphilis using an Electrochemical Readout based on DNA Switches, G5778863706, G5813238744, G589846866, G6054710752, G6080697404, G6122222817, G6196935697, MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response, G6328075693, G6466088583, G6520718613, G6532547617, G702470302, G7084143925, G7208110030, G7283494489, G7358480839, G7929877481, G8380837799, PREvention of MOther-to-child Transmission of HIV and Syphilis using an Electrochemical Readout based on DNA Switches, G887491987, G897484643, G99296377
OpenAlex ID: W4294805149
